These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2279337)

  • 21. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cultured allogeneic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers.
    Harvima IT; Virnes S; Kauppinen L; Huttunen M; Kivinen P; Niskanen L; Horsmanheimo M
    Acta Derm Venereol; 1999 May; 79(3):217-20. PubMed ID: 10384921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers.
    Moustafa M; Bullock AJ; Creagh FM; Heller S; Jeffcoate W; Game F; Amery C; Tesfaye S; Ince Z; Haddow DB; MacNeil S
    Regen Med; 2007 Nov; 2(6):887-902. PubMed ID: 18034628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced multi-targeted composite biomaterial dressing for pain and infection control in chronic leg ulcers.
    Catanzano O; Docking R; Schofield P; Boateng J
    Carbohydr Polym; 2017 Sep; 172():40-48. PubMed ID: 28606546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organotypic cultures of autologous hair follicle keratinocytes for the treatment of recurrent leg ulcers.
    Limat A; French LE; Blal L; Saurat JH; Hunziker T; Salomon D
    J Am Acad Dermatol; 2003 Feb; 48(2):207-14. PubMed ID: 12582390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers.
    Meaume S; Ourabah Z; Cartier H; Granel-Brocard F; Combemale P; Bressieux JM; Bohbot S
    J Wound Care; 2005 Jul; 14(7):329-34. PubMed ID: 16048220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amniotic membrane transplantation in the treatment of chronic lower limb ulcers.
    Alsina-Gibert M; Pedregosa-Fauste S
    Actas Dermosifiliogr; 2012 Sep; 103(7):608-13. PubMed ID: 22578292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.
    Yonezawa M; Tanizaki H; Inoguchi N; Ishida M; Katoh M; Tachibana T; Miyachi Y; Kubo K; Kuroyanagi Y
    Int J Dermatol; 2007 Jan; 46(1):36-42. PubMed ID: 17214717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dressings and topical agents for arterial leg ulcers.
    Nelson EA; Bradley MD
    Cochrane Database Syst Rev; 2003; (1):CD001836. PubMed ID: 12535417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leg ulcer: proposal of a new method for comparing different wound dressings].
    Ebner H; Zaraca F; Ebner JA; Stringari C
    Chir Ital; 2008; 60(4):563-6. PubMed ID: 18837258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of two fibrous wound dressings for the management of leg ulcers: results of a European randomised controlled trial (EARTH RCT).
    Meaume S; Dissemond J; Addala A; Vanscheidt W; Stücker M; Goerge T; Perceau G; Chahim M; Wicks G; Perez J; Tacca O; Bohbot S
    J Wound Care; 2014 Mar; 23(3):105-6,108-11, 114-6. PubMed ID: 24633056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cultured epidermal grafts in the treatment of leg ulcers.
    Phillips TJ; Gilchrest BA
    Adv Dermatol; 1990; 5():33-48; discussion 49. PubMed ID: 2204378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology.
    Romanelli M; Dini V; Bertone MS
    Adv Skin Wound Care; 2010 Jan; 23(1):34-8. PubMed ID: 20101114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irrigation treatment of leg ulcers.
    Svedman P
    Lancet; 1983 Sep; 2(8349):532-4. PubMed ID: 6136691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of venous leg ulcer by French physicians, diversity and related costs: a prospective medicoeconomic observational study].
    Lévy E; Lévy P
    J Mal Vasc; 2001 Feb; 26(1):39-44. PubMed ID: 11240528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leg ulcers. Treating chronic venous ulcers.
    Taylor S; Hoile A
    Nurs Times; 1986 May 28-Jun 3; 82(22):33-7. PubMed ID: 3636879
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid healing of long-lasting sickle cell leg ulcer treated with allogeneic keratinocytes.
    Amini-Adle M; Auxenfants C; Allombert-Blaise C; Deroo-Berger MC; Ly A; Jullien D; Faure M; Damour O; Claudy A
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):707-8. PubMed ID: 17448004
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical haemotherapy for leg ulcers.
    Triquet B; Ruffieux P; Mainetti C; Salomon D; Saurat JH
    Dermatology; 1994; 189(4):418-20. PubMed ID: 7873834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of the treatment of chronic wounds: hydroactive wound dressings in combination with enzymatic ointment versus gauze dressings in patients with pressure ulcer and venous leg ulcer in Germany.
    Bergemann R; Lauterbach KW; Vanscheidt W; Neander KD; Engst R
    Pharmacoeconomics; 1999 Oct; 16(4):367-77. PubMed ID: 10623365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grafting of leg ulcers with undifferentiated keratinocytes.
    Brysk MM; Raimer SS; Pupo R; Bell T; Rajaraman S
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 1):238-44. PubMed ID: 1918459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.